










Objective: This article aims to assess the effect of transcutaneous electrical stimulation or ultrasound 
therapy in the treatment of post-mastectomy upper limb lymphedema. Method: A systematic 
literature review was performed from 1980 to 2012 from the MedLine, Cochrane Library, LILACS 
and SciELO databases. The terms used in the search were (breast neoplasm OR breast cancer OR 
lymphedema) and (hyperthermia, induced OR diathermy OR ultrasonic therapy OR ultrasound OR 
transcutaneous electrical nerve stimulation OR TENS). The selections of the studies concerned 
female patients with post-mastectomy upper limb lymphedema who underwent diathermy by 
ultrasound therapy and transcutaneous electric nerve stimulation. Only randomized (RCT) and 
quasi-randomized study designs were included (both Narrow and Broad Therapy). Only studies 
published in the full paper format were included. After reviewing the 2,158 abstracts resulting 
from the search, only two papers were selected. Two researchers analyzed the two articles, using 
the Van Tulder and JADAD scales for quality assessment. Results: Both papers evaluated the use 
of ultrasound therapy and electric stimulation for treatment of post-mastectomy lymphedema. 
A total of 132 subjects were included in these two studies, and little improvement was observed 
in pain reduction or quality of life. Only the study using ultrasound therapy identified a small 
reduction in lymphedema symptoms; however, evidence supporting the application of this 
method is lacking. Conclusion: Further studies are needed to evaluate the use of ultrasound 
therapy or electrotherapy for treatment of post-mastectomy lymphedema and to evaluate the 
potential effect of these therapies on later development of metastatic disease.
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RESUMO
Objetivo: Avaliar o efeito da estimulação elétrica transcutânea ou terapia de ultra-som no 
tratamento de pós-mastectomia linfedema do membro superior. Método: revisão sistemática 
da literatura foi realizada 1980-2012 do MedLine, Cochrane Library, LILACS e SciELO. Os termos 
utilizados na pesquisa foram (neoplasia de mama ou câncer de mama ou de linfedema) e 
(hipertermia, induzido ou diatermia ou terapia de ultra-som ou ultra-som ou a estimulação 
elétrica nervosa transcutânea ou dezenas). As seleções dos estudos eram de pacientes mulheres 
com linfedema pós-mastectomia membro superior que foram submetidos a diatermia por terapia 
de ultra-som e estimulação elétrica nervosa transcutânea. Só randomizado (RCT) e projetos quase 
randomizados do estudo foram incluídos (ambos estreita e Broad Therapy). Somente estudos 
publicados no formato de artigo completo foram incluídos. Depois de analisar os 2.158 resumos 
resultantes da pesquisa, foram selecionados apenas dois artigos. Dois pesquisadores analisaram os 
dois artigos, usando o Van Tulder e JADAD escalas para avaliação da qualidade. Resultados: Ambos 
os trabalhos avaliaram o uso da terapia de ultra-som e estimulação elétrica para o tratamento do 
linfedema pós-mastectomia. Um total de 132 indivíduos foram incluídos em ambos os estudos, e 
pouca melhora foi observada em redução ou a qualidade de vida da dor. Somente o estudo usando 
a terapia de ultra-som identificada uma pequena redução nos sintomas de linfedema. No entanto 
evidências que suportam a aplicação deste método está faltando. Conclusão: Mais estudos são 
necessários para avaliar o uso da terapia de ultra-som ou eletroterapia para o tratamento de 
linfedema pós-mastectomia e para avaliar o efeito potencial dessas terapias no desenvolvimento 
posterior da doença metastática.
Palavras-chave: Neoplasias da Mama, Linfedema, Reabilitação, Estimulação Elétrica Nervosa 
Transcutânea
Terapia de ultrassom e estimulação elétrica transcutânea 
neuromuscular para a tratamento do linfedema de membro 
superior pós-mastectomia
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INTRODUCTION
Almost 1.4 million women worldwide 
were diagnosed with breast cancer in 2008 
and approximately 459,000 deaths were re-
gistered. The estimated 5-year survival rate 
varies from almost 90% in the United States of 
America, Australia, and Canada, to 12% in cer-
tain regions of Africa. This difference is related 
to a combination of early detection, access to 
treatment, and cultural barriers. Approxima-
tely 230,000 new invasive breast cancer ca-
ses were likely diagnosed in 2012, and almost 
40,000 patients aged between 40 and 59 years 
will die as a result of this disease.1
Lymphedema is one complication that can 
result from disruption of post-breast cancer 
ganglion drainage. It is a poorly understood, 
relatively underestimated, and little studied 
disease entity. Reported incidence rates for 
secondary lymphedema vary depending on 
the method used for measurement. Incon-
sistent definitions and the lack of a standard 
classification system have resulted in diverse 
incidence rates for secondary lymphedema, 
ranging from 2.4% to 56% within 2 years af-
ter surgery.2 Most women (71%) develop 
secondary lymphedema within 12 months 
after surgery for breast cancer, although the 
condition may occur within a few days and up 
to 30 years after initiation of treatment.3
Lymphedema can result in significant phy-
sical and psychological morbidity. Swelling 
causes a disproportionate increase in the size 
of the body part and thus can interfere with 
mobility and affect the patients’ body image.4 
In addition to an increase in size, the affected 
subcutaneous tissues gradually thicken and 
become fibrotic, creating a solid component 
of swelling.5 Pain and discomfort are among 
the physical problems associated with lym-
phedema, in addition to recurrent attacks of 
infection/inflammation. The latter are a re-
sult of reduced local immunity in the affected 
part of the body. The limb shape can become 
distorted.6 Post-breast cancer lymphedema 
may also significantly influence function and 
quality of life.7
There is no cure for lymphedema, and 
after its occurrence, regression is difficult to 
achieve. The main goals of treatment are con-
trolling volume increases in the affected limb, 
alleviating symptoms, and generally preven-
ting complications related to lymphedema.8 
Because drugs are not very beneficial for the 
treatment of lymphedema, rehabilitation 
programs that combine massage, skin care, 
exercises, and compressive methods are the 
treatments of choice.9 Complex decongestive 
physical therapy (CDPT), the most well-studied 
treatment, is a combined program that incor-
porates manual lymph drainage, multi-layer 
short-stretch bandaging, exercise, and skin 
care. CDPT has been recommended by a con-
sensus panel of experts and is considered to 
be the standard approach to lymphedema ma-
nagement.10 Several elements of CDPT have 
proven efficacy, with reports of an approxima-
tely 50% initial reduction in the measured ex-
cess limb volume. Other therapeutic options 
include intermittent pneumatic compression 
therapy (IPC), Manual Lymphatic Drainage 
(MLD), constraint therapies with elastic ban-
dages, kinesiotherapy, surgery, and more 
recently, laser treatment.10-12
According to the literature, the therapeu-
tic benefits of transcutaneous electrical neu-
romuscular stimulation (TENS) or ultrasound 
therapy (US) remain controversial, in spite of 
the biophysical effects of these therapies.13-17 
The justification for using US to treat lym-
phedema is the “soft action” exerted through 
wave propagation at the cellular level, with 
a slight heat (joule effect) that modifies cell 
metabolism and microcirculation. It is thought 
that these processes may promote lymph flow 
and possibly reduce the firmness and fibrosis 
commonly observed after CDPT. The proposed 
mechanism of electrotherapy is similar to that 
of manual lymphatic drainage. Both therapies 
return lymph to lymphatic circulation, though 
electrotherapy may have an additional mole-
cular protein activation effect.
Jahr et al.18 used intermittent, low inten-
sity, extremely low frequency electrostatic 
fields to stimulate lymphatic flow by deep re-
sonance vibration. They reported alleviation 
of pain and reduction of swelling in patients 
with breast lymphedema related to breast 
cancer. Ricci19 evaluated the effects of an 
electro-medical instrument that uses low-fre-
quency and low-intensity electrotherapy to 
treat lymphedema by activating the biological 
structures contained in the lymph through the 
physical process of bioresonance. He applied 
this therapy to 50 patients and used lymphos-
cintigraphy to verify the effects. The study 
concluded that the treatment stimulates lym-
ph flow, activates apical limb lymph nodes and 
reduces dermal back flow. They reported that 
the low-frequency low-intensity electrothera-
py system was useful in diminishing the volu-
me and the ‘feeling of gravity and hardening’. 
While the study by Ricci19 provided the first 
published data on the effect of electric fields 
for the treatment of upper and lower limb 
lymphedema, there was no information re-
ported regarding the magnitude of the effects. 
Zhang et al.20 studied 1,045 patients with chro-
nic lymphedema and demonstrated a volume 
reduction after heat and bandage treatment.
Despite these promising results, studies 
using modalities that generate heat or electrici-
ty in cancer patients have been conducted with 
caution. The published results are promising 
and the method is simple. However, American 
experts in physical medicine and rehabilita-
tion have long advised that any modality that 
generates electricity or heat (e.g., shortwave 
diathermy, microwave diathermy) should be 
used with caution in people with active can-
cer, due to the possibility of increasing tumor 
growth and metastasis. A well-controlled, ran-
domized trial involving mice receiving subcuta-
neous injections of tumor cells demonstrated 
that therapeutic ultrasound led to increases in 
tumor growth, although it did not increase the 
occurrence of metastasis.21 Because it is often 
unknown whether breast cancer is truly in re-
mission, the possibility of recurrence (i.e., acti-
ve cancer) should always be considered.
In spite of the above considerations, US 
and electrotherapy are common and longtime 
key modalities used in rehabilitation. Moreo-
ver, the possibility of maximizing positive ou-
tcomes in breast cancer patients without side 
effects through the use of appropriate reha-
bilitation approaches provides an important 
opportunity for involving the rehabilitation 
team in the care of cancer patients.
Based on this notion, the present syste-
matic review evaluates the effects of using 
transcutaneous electrical stimulation and/or 
ultrasound in the treatment of post-mastec-
tomy upper-limb lymphedema. This study fo-
cuses on US and electrotherapy treatment in 
the context of clinical benefits and lymphede-
ma reduction as well as studies investigating 
possible side effects such as increased tumor 
growth or metastasis.
OBJECTIVE
The objective of this study was to assess 
the effects of transcutaneous electrical stimu-
lation and ultrasound therapy in the treatment 
of post-mastectomy upper limb lymphedema.
METHOD
This paper is the result of a systematic 
literature review, from the period between 
1980 and 2012, which was performed using 
the MedLine, Cochrane Library, LILACS, IBECS, 
and SciELO databases. The MeSh terms were 
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identified, and the PICO search strategy me-
thodology was used, where P = patient, I = in-
tervention, C = comparison among therapies, 
and O = outcome. The search was performed 
with the use of the following terms: (breast 
neoplasm OR breast cancer OR lymphedema) 
and (hyperthermia, induced OR diathermy OR 
ultrasonic therapy OR ultrasound OR transcu-
taneous electric nerve stimulation OR TENS).
The following articles were found by the 
search outlined above: Case Reports (1,497); 
Clinical Prediction Guides/Broad (2,042); 
Clinical Trial (561); Diagnosis/Broad (6,195); 
Etiology/Broad (3,131); Humans (8,206); Me-
ta-analysis (19); Multicenter Study (145); Prog-
nosis/Broad (2,309); Review (1,169); Therapy/
Broad (1,999); and Therapy/Narrow (159).
Inclusion and exclusion criteria
• Type of population: female patients 
who presented with post-mastec-
tomy upper limb lymphedema.
• Types of studies: according to the ob-
jective of this study, i.e., treatment 
analysis, only clinical trials were as-
sessed (both Narrow and Broad The-
rapy). Randomized (RCT) and qua-
si-randomized study designs were 
included. Quasi-randomized studies 
were defined as those that do not 
strictly adhere to randomized me-
thods of allocation, i.e., allocation by 
order of admission, date of birth, or 
some other method that is not truly 
random. Only full paper publications 
were deemed acceptable for review.
• Types of interventions: induced or 
diathermy by ultrasound therapy 
and transcutaneous electrical nerve 
stimulation.
• Types of outcome measures: at least 
one key symptom of lymphedema, 
including subjective circulation, pain, 
physical function, and/or decreased 
fibrosis. Secondary outcome mea-
sures included adverse events such 
as the risk of inducing metastasis - 
including bone metastasis - in active 
cancer patients, or the potential for 
relapse in areas such as the ribs, tho-
racic wall, or axillae. The hematoge-
nous dissemination of these metas-
tases was thought to be due to the 
thermal effect of ultrasound therapy 
through promotion of heat produc-
tion and enlargement of the blood 
vessels or through increasing the 
nutritional blood flow to the tissues, 
which also favors tissue regeneration.
After completing the search and reading the 
narrow therapy abstracts, 157 of 159 were ex-
cluded, as they did not focus on the treatment 
of post-mastectomy lymphedema, but instead 
on diagnosing or treating lymphedema due to 
other causes. Only 2 of the articles, according 
to the abstracts, were pertinent to our resear-
ch question. After evaluation of the complete 
articles, we excluded one of them because the 
treatment of lower-limb lymphedema was not 
within the scope of the present study. Appro-
ximately 1,999 broad therapy articles were 
found. After evaluating the abstracts, 1,993 
were excluded and 7 complete articles were 
evaluated. Five of those were excluded for not 
using US or TENS. One study was excluded be-
cause the lymphedema was not assessed using 
volumetric or circumferential measurement.
The analyses of the two selected articles 
were performed by two researchers using 
the Van Tulder and JADAD scales for quality 
assessment.
The Van Tulder criteria score trials accor-
ding to 19 items: 11 items assess internal va-
lidity, 6 items assess descriptive quality, and 2 
items assess statistical validity. The maximum 
Van Tulder score is 18 points. Trials are consi-
dered to be of high methodological quality if 
their internal validity is ≥ 5/10. To take a more 
comprehensive look at the methodological 
quality, the trials in this review were categori-
zed according to the following criteria:
• High quality trials: At least 70% of the 
methodological criteria met an inter-
nal validity of ≥ 6/10;
• Medium quality trials: At least 50% of 
methodological criteria met internal 
validity of 5/10;
• Low quality trials. At least 50% of me-
thodological criteria met plus inter-
nal validity < 5/10.
RESULTS
According to the methodology described 
above, two articles were included, one using 
narrow therapy and the other broad therapy 
(Chart 1).
It was noted that one of the articles was 
considered to be of low quality, with a Van Tul-
der score of 3 and JADAD score of 1.
The results were 9,607 records identified, 
12 records after duplicates were removed, 
2,158 records screened, and 2,149 records 
excluded. Nine full text articles were assessed 
for eligibility and 7 were excluded because 
they did not use either US or TENS. Qualitative 
synthesis was 2 articles.
Study characteristics
Participants and Interventions
A total of 132 subjects were included from 
the two studies; 36 from Belmonte et al.22 and 
96 from Balzarini et al.23
Belmonte et al.22 randomized 36 patients 
into two intervention groups (A and B); the 
objective was to compare the efficacy of 
low-frequency, low-intensity electrotherapy 
vs. manual lymphatic drainage for the treat-
ment of chronic upper limb breast cancer-re-
lated lymphedema. The design was a crosso-
ver single-blind randomized clinical trial in a 
rehabilitation setting. Thirty-six women with 
chronic upper limb breast cancer-related 
lymphedema were enrolled.
Patients were recruited by the physician 
in an outpatient hospital rehabilitation setting 
between March 2008 and July 2009. Inclusion 
criteria were the presence of breast cancer-re-
lated lymphedema, completion of the intensi-
ve phase of complex decongestive therapy for 
lymphedema, initiation of the maintenance 
phase at least 1 year prior to the study, and 
a documented therapeutic clearance period 
with no manual lymphatic drainage treatment 
for at least 6 months. Exclusion criteria were 
the following: (1) the presence of a pace-
maker, heart disease, pregnancy, metallic de-
vices in the affected limb, infectious disease, 
epilepsy, thrombophlebitis, arterial hyperten-
sion and metastasis, and (2) the presence of 
mental, sensory, or language problems which 
could hinder participation. At recruitment, pa-
tients had a mean age of 67.8 years, and their 
average body mass index was 30.5 kg/m2. All 
patients had been surgically treated, 56% by 
breast-conserving surgery. All patients had 
undergone axillary node dissection, while only 
four had previously undergone a sentinel lym-
ph node biopsy. Almost all patients (87.5%) 
used compression garments (four patients did 
not use garments because of skin problems or 
personal choice), and 46.9% had a history of 
cutaneous infectious complications.
Patients were randomized to undergo ei-
ther low-frequency low-intensity electrothe-
rapy followed by manual lymphatic drainage 
(group A with 19 patients), or 10 sessions of 
manual lymphatic drainage followed by 10 ses-
sions of low-frequency low-intensity electro-
therapy (group B with 17 patients). There was 
a month of washout time between treatments.
Physicians who examined the patients and 
performed the data analysts were blinded to 
the treatment received. To ensure that blin-
ding was successful, patients were advised not 
to mention their treatment during physician 
evaluation, except for adverse effects. There 
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Chart 1. Description of the articles included
Year Author Country Intervention Outcome Result
2011 Belmonte et al.22 Spain Low frequency TENS and Manual Lymphatic Drainage
Comparing the effectiveness of TENS and 
MLD in the reduction of post-mastectomy 
lymphedema
No significant differences were observed 
between manual lymphatic drainage and 
low-frequency TENS, there was reduction of 
lymphedema, alleviation of pain, sensation 
of weight, constraint, and improvement in 
quality of life.
1993 Balzarini et al.23 Italy
Ultrasound Therapy (UST) and elastic 
compression, UST with no other physical 
means; Mechanical Compressive Therapy 
(MCT) and elastic compression and MCT 
with no other physical means.
Comparing the effectiveness of UST applied 
to the acupuncture points of the upper limb: 
ST (stomach), LU (lung), LI (lower intestine), 
SI (smaller intestine), SJ (San Jiao), and HT 
(heart), with the MCT either associated or 
not with elastic
In the ultrasound group, the average arm 
size was reduced by about 8.78% and in 
the mechanical compression about 9.13%. 
No additional improvement was observed 
combining the use of elastic compression 
with UST or MCT.
were no reported adverse effects resulting 
from the manual lymphatic drainage treat-
ment. It was verified that one patient suffered 
an episode of erysipelas on the fourth day of 
treatment with low frequency and intensity 
electrotherapy. This patient refused to go to 
a hospital for evaluation until 3 weeks later, at 
which point the erysipelas had disappeared. 
Another patient presented with erythema on 
the back of her hand on the third day of elec-
trotherapy, which was attributed to a crease 
in her clothes. When the clothing item was re-
moved, after 2 days, the erythema abated and 
she continued with the treatment sessions. A 
third patient presented with irritation on her 
skin at the spot where the electrode was at-
tached for electrotherapy. When the intensity 
was reduced, her symptoms abated and she 
was able to complete all treatment sessions. A 
physiotherapist with expertise in lymphedema 
treatment performed both treatments. During 
both treatment periods, the maintenance 
phase of complex decongestive therapy was 
continued: compression therapy using adap-
ted garments (sleeves and gloves) was utili-
zed, and patients were reminded to continue 
exercises and skin care.
In the study by Balzarini et al.,23 96 pa-
tients were randomized into four groups as 
follows: 35 patients used mechanical pressure 
therapy (MPT) and elastic sleeves; 30 patien-
ts used only mechanical pressure therapy; 15 
patients used ultrasound therapy and elastic 
sleeves; and 16 patients used only ultrasound 
therapy. In both US groups, the US was per-
formed on the lymphedema-affected upper 
limb using acupuncture points of the following 
local meridians: ST (stomach), LU (lungs), LI 
(lower intestine), SI (small intestine), SJ (san 
jiao), and HT (heart), according to the swollen 
areas, with a total of 10 sessions. Ultrasound 
was applied in 3 cycles using the following pa-
rameters: 30-minute duration per day for 10 
consecutive days, using 2 watt/cm2 power at 
a frequency of 3 MHz for 5-second cycles. The 
MPT parameters were 6 hours per day for 5 
consecutive days at a pressure of 40 mmHg 
for 1 year with a 4-month interval for follow 
up and lymphedema measurement of the af-
fected limb using the contralateral limb as a 
control. Twelve patients reportedly left the 
study, 5 in the US group due to cancer recur-
rence, and 7 in MPT group for not adhering to 
the treatment protocol. In both US groups, 11 
patients had undergone radical mastectomy 
without radiotherapy, and 20 were submitted 
to quadrantectomy with axillary dissection 
and radiotherapy. In both MPT groups, 19 pa-
tients had undergone radical mastectomy and 
46 conservative operations were performed. 
The interval between surgical intervention 
and the onset of arm edema ranged from 3 to 
52 months in the US groups, and from 5 to 57 
months in the MPT groups.
Effects of interventions
Lymphedema
In both studies, the lymphedema was 
evaluated measuring circumference to assess 
the reduction in edema. In one of the studies, 
this method was also used for comparison 
with the contralateral limb.23
In the study by Belmonte et al.,22 the-
re were no differences between the groups. 
When comparing the effects of low-frequency 
low-intensity electrotherapy with manual 
lymphatic drainage, there were no signifi-
cant differences in lymphedema, except for 
a marginally significant reduction of pain 
that was greater in group A (13.1 vs. 1.07 
mm) (p = 0.05). Analysis before and after 
low-frequency low-intensity electrothera-
py treatment data showed a non-significant 
lymphedema volume reduction of 19.77 mL 
(p = 0.36). Although statistically significant 
benefits were observed in the low-frequency 
low-intensity electrotherapy group with re-
gards to most symptoms and the health-rela-
ted quality of life, the observed benefits were 
not significantly different from those observed 
in the manual lymphatic drainage group. The 
edema was reduced by practically the same 
proportion in both groups22 with no great di-
fferences in limb size pre- and post-treatment.
The Balzarini et al.23 study reported a 
greater reduction in volume after the first 4 
months of treatment in the US group; howe-
ver, this effect did not persist at 12 months. 
At baseline, the mean arm size-difference was 
8.78% in the US groups and 9.13% in the MPT 
groups, which is not a significant difference. 
After 12 months, the size difference was 6.88% 
in the US groups and 7.55% in the MPT groups, 
which is also not a significant difference.
US was as effective as MCT with regards 
to edema reduction, but was better tolerated 
than MCT.23 It was noted that the use of an elas-
tic sleeve did not produce any additional impro-
vement in the percentage of volume reduction.
Pain
Pain was assessed in the Belmonte et al.22 
study using the VAS score. Pain, heaviness, 
and tightness were significantly reduced af-
ter electrotherapy; however, no significant 
differences were observed when compared 
to manual lymphatic drainage. Nonetheless, 
there was no statistically significant difference 
between low-frequency low-intensity electro-
therapy and manual lymphatic drainage for 
these symptoms.
Fibrosis
Tissue fibrosis was evaluated in the study 
by Balzarini et al.,23 who found a reduction 
in fibrosis with a greater degree of subjecti-
vely perceived tissue softening in the ultra-
sound-treated group.
DISCUSSION
This paper is a systematic literature review 
spanning the period between 1980 and 2012 
that aimed to assess the effects of transcuta-
neous electrical stimulation and ultrasound 
therapy in the treatment of post-mastectomy 
upper limb lymphedema. Our search and 
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methodological strategy resulted in just two 
randomized clinical studies focused on the 
treatment of post-breast cancer surgery lym-
phedema with US or TENS: one of high quality 
and one of low quality. Neither of the studies 
referred to the margin of safety related to the 
region of application of US or TENS, due to 
active areas or areas with a high potential for 
breast cancer metastasis, including bone me-
tastasis to the ribs, thoracic wall, or axillae.24,25
Belmonte et al.22 is the first study to com-
pare low-frequency low-intensity electrothe-
rapy to manual lymphatic drainage for several 
relevant outcomes (limb volume, pain, heavi-
ness, tightness, and health-related quality of 
life) in patients with chronic breast cancer-re-
lated lymphedema. Although the benefits of 
electrotherapy on most symptoms and the 
health-related quality of life were significant, 
they were not significantly different from tho-
se observed with manual lymphatic drainage. 
In fact, any improvement in health-related 
quality of life was merely observed.22 In terms 
of lymphedema volume change, the effect of 
low-frequency low-intensity electrotherapy 
was negligible, as was the effect of manual 
lymphatic drainage. This was likely because 
treatment was utilized in a sample of pre-
viously treated patients with well-controlled 
lymphedema who were in the maintenance 
phase of treatment. This aspect may have li-
mited the potential degree of the benefit, as 
the patients’ disease was well controlled with 
previous periodic treatment sessions (once or 
twice per year) with manual lymphatic draina-
ge. Moreover, most patients (87.5%) regularly 
used compression garments, which is an im-
portant factor in stabilizing lymphedema vo-
lume in the maintenance phase. However, the 
treatment was well-tolerated, and there were 
no significant adverse effects observed. This 
trial also had significant limitations. The small 
sample size and the fact that patients were 
not blinded to the treatment they received 
presented the greatest potential for bias. Ad-
ditionally, including only chronic lymphedema 
patients limits the conclusion to only the chro-
nic phase. The effect of electrotherapy in ear-
ly lymphedema and in the intensive phase of 
lymphedema treatment would require future 
studies. In addition, the study was designed to 
determine the immediate effect after 10 ses-
sions of treatment with no further follow-up. 
Lastly, both treatments showed additional 
benefits when administered in sequence. This 
could indicate that combined treatments may 
result in greater therapeutic benefits than 
electrotherapy alone. Taking these observa-
tions into account, more studies are needed 
to assess the effects of electrotherapy in the 
management of lymphedema patients in all 
phases of treatment.
The study by Balzarini et al.,23 which exa-
mined the use of Ultrasound Therapy (US) and 
Mechanical Pressure Therapy (MPT), isolated 
or associated with elastic compression, did 
not show a great difference in the reduction 
of edema. However, the US treatment was 
better tolerated than MCT.23 Additionally, al-
though there was a similar degree of volume 
reduction in both groups, there was a greater 
degree of subjectively perceived tissue softe-
ning in the ultrasound-treated group. More 
studies are warranted to assess whether US 
therapy is effective and safe for the treatment 
of lymphedema patients.
CONCLUSION
The two trials included in this review both 
have their limitations and have yet to be re-
plicated, so the results must be viewed with 
caution. There is weak evidence to support the 
use of US or electrotherapy in the treatment of 
breast cancer related lymphedema. Moreover, 
determination of the relationship between the-
se therapies and the risk of metastasis would 
require longer patient follow-up times. In these 
two studies, the use of US or electrotherapy 
in the treatment of chronic upper limb breast 
cancer-related lymphedema did not result in 
significant lymphedema reduction. There was 
a marginally significant reduction of pain after 
TENS therapy. Therefore, there is insufficient 
evidence for recommendation.
Trials of complex physical therapy pro-
grams are not easy to conduct, but still pos-
sible. Moreover, the potential for safely maxi-
mizing the positive outcomes of breast cancer 
rehabilitation through the use of appropriate 
rehabilitation techniques presents an oppor-
tunity for involving physiatrists and the reha-
bilitation team in the care of cancer patients. 
There is a clear need for well-designed rando-
mized trials to address the use of physical mo-
dalities in the treatment of breast cancer-rela-
ted lymphedema.
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